XML 17 R7.htm IDEA: XBRL DOCUMENT v3.25.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
Total
Class A and B common stock
Common stock and additional paid in capital
Accumulated other comprehensive loss
Retained earnings (Accumulated deficit)
Noncontrolling interests
Beginning balance (in shares) at Dec. 31, 2023   615,821        
Beginning balance at Dec. 31, 2023 $ 18,692,836   $ 19,601,992 $ (378,307) $ (528,429) $ (2,420)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) 470,820       472,005 (1,185)
Shares issued in connection with employee stock plans (in shares)   4,806        
Shares issued in connection with employee stock plans 19,943   19,943      
Repurchases of common stock (in shares)   (3,563)        
Repurchases of common stock (252,095)   (252,095)      
Change in other comprehensive income (loss) (281,896)     (281,896)    
Share-based compensation 317,588   317,588      
Ending balance (in shares) at Mar. 31, 2024   617,064        
Ending balance at Mar. 31, 2024 18,967,196   19,687,428 (660,203) (56,424) (3,605)
Beginning balance (in shares) at Dec. 31, 2024   619,676        
Beginning balance at Dec. 31, 2024 21,234,962   19,900,379 (1,001,065) 2,368,618 (32,970)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) 188,722       189,872 (1,150)
Shares issued in connection with employee stock plans (in shares)   4,004        
Shares issued in connection with employee stock plans 2,283   2,283      
Repurchases of common stock (in shares)   (6,805)        
Repurchases of common stock (445,298) $ (445,300) (445,298)      
Change in other comprehensive income (loss) 130,250     130,250    
Share-based compensation 324,155   324,155      
Ending balance (in shares) at Mar. 31, 2025   616,875        
Ending balance at Mar. 31, 2025 $ 21,435,074   $ 19,781,519 $ (870,815) $ 2,558,490 $ (34,120)